Pawel Renc

Pawel Renc

Auto-generated profile, based on publicly available information

Pawel Renc

Department of Radiology, Massachusetts General Hospital, Boston, MA, United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2024 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
PRPawel Renc
Pawel Renc
YJYugang Jia
Yugang Jia
ASAnthony E. Samir
Anthony E. Samir
JWJaroslaw Was
Jaroslaw Was
QLQuanzheng Li
Quanzheng Li
ASArkadiusz Sitek
Arkadiusz Sitek
Integrating modern machine learning and clinical decision-making has great promise for mitigating healthcare’s increasing cost and complexity. We introduce the Enhanced Transformer for Health Outcome Simulation (ETHOS), a novel application of the transformer deep-learning architecture for analyzing high-dimensional, heterogeneous, and episodic health data. ETHOS is trained using Patient Health Timelines (PHTs)—detailed, tokenized records of health events—to predict future health trajectories, leveraging a zero-shot learning approach. ETHOS represents a significant advancement in foundation model development for healthcare analytics, eliminating the need for labeled data and model fine-tuning. Its ability to simulate various treatment pathways and consider patient-specific factors positions ETHOS as a tool for care optimization and addressing biases in healthcare delivery. Future developments will expand ETHOS’ capabilities to incorporate a wider range of data types and data sources. Our work demonstrates a pathway toward accelerated AI development and deployment in healthcare.

6 January 2025 in GigaScience
Verified
Journal Article
Open access
PRPawel Renc
Pawel Renc
MGMichal K Grzeszczyk
Michal K Grzeszczyk
NONassim Oufattole
Nassim Oufattole
DGDeirdre Goode
Deirdre Goode
YJYugang Jia
Yugang Jia
ASArkadiusz Sitek
Arkadiusz Sitek
Background: Hospitals struggle to predict critical outcomes. Traditional early warning systems, like NEWS and MEWS, rely on static variables and fixed thresholds, limiting their adaptability, accuracy, and personalization. Methods: We previously developed the Enhanced Transformer for Health Outcome Simulation (ETHOS), an artificial intelligence (AI) model that tokenizes patient health timelines (PHTs) from electronic health records and uses transformer-based architectures to predict future PHTs. ETHOS is a versatile framework for developing a wide range of applications. In this work, we develop the Adaptive Risk Estimation System (ARES) that leverages ETHOS to compute dynamic, personalized risk probabilities for clinician-defined critical events. ARES also features a personalized explainability module that highlights key clinical factors influencing risk estimates. We evaluated ARES using the MIMIC-IV v2.2 dataset, together with its emergency department extension, and benchmarked performance against both classical early warning systems and contemporary machine learning models. Results: The entire dataset was tokenized, resulting in 285,622 PHTs (63% with at least 1 hospital admission), comprising over 357 million tokens. ETHOS outperformed benchmark models in predicting hospital admissions, intensive care unit admissions, and prolonged stays, achieving superior area under the curve scores. Its risk estimates were robust across demographic subgroups, with calibration curves confirming model reliability. The explainability module provided valuable insights into patient-specific risk factors Conclusions: ARES, powered by ETHOS, advances predictive health care AI by delivering dynamic, real-time, personalized risk estimation with patient-specific explainability. Although our results are promising, the clinical impact remains uncertain. Demonstrating ARES’s true utility in real-world settings will be the focus of our future work.

17 December 2022 in Journal of Human Hypertension
Verified
Journal Article
Open access
PDF file
EMEleanor C. Murray
Eleanor C. Murray
CDChristian Delles
Christian Delles
POPatryk Orzechowski
Patryk Orzechowski
PRPawel Renc
Pawel Renc
ASArkadiusz Sitek
Arkadiusz Sitek
TGTomasz J. Guzik
Tomasz J. Guzik
The study characterises vascular phenotypes of hypertensive patients utilising machine learning approaches. Newly diagnosed and treatment-naïve primary hypertensive patients without co-morbidities (aged 18–55, n = 73), and matched normotensive controls (n = 79) were recruited (NCT04015635). Blood pressure (BP) and BP variability were determined using 24 h ambulatory monitoring. Vascular phenotyping included SphygmoCor® measurement of pulse wave velocity (PWV), pulse wave analysis-derived augmentation index (PWA-AIx), and central BP; EndoPAT™-2000® provided reactive hyperaemia index (LnRHI) and augmentation index adjusted to heart rate of 75bpm. Ultrasound was used to analyse flow mediated dilatation and carotid intima-media thickness (CIMT). In addition to standard statistical methods to compare normotensive and hypertensive groups, machine learning techniques including biclustering explored hypertensive phenotypic subgroups. We report that arterial stiffness (PWV, PWA-AIx, EndoPAT-2000-derived AI@75) and central pressures were greater in incident hypertension than normotension. Endothelial function, percent nocturnal dip, and CIMT did not differ between groups. The vascular phenotype of white-coat hypertension imitated sustained hypertension with elevated arterial stiffness and central pressure; masked hypertension demonstrating values similar to normotension. Machine learning revealed three distinct hypertension clusters, representing ‘arterially stiffened’, ‘vaso-protected’, and ‘non-dipper’ patients. Key clustering features were nocturnal- and central-BP, percent dipping, and arterial stiffness measures. We conclude that untreated patients with primary hypertension demonstrate early arterial stiffening rather than endothelial dysfunction or CIMT alterations. Phenotypic heterogeneity in nocturnal and central BP, percent dipping, and arterial stiffness observed early in the course of disease may have implications for risk stratification.

11 November 2023
Verified
Conference Paper
Open access
MBMaciej Besta
Maciej Besta
PRPawel Renc
Pawel Renc
RGRobert Gerstenberger
Robert Gerstenberger
PLPaolo Sylos Labini
Paolo Sylos Labini
AZAlexandros Ziogas
Alexandros Ziogas
THTorsten Hoefler
Torsten Hoefler
Graph attention models (A-GNNs), a type of Graph Neural Networks (GNNs), have been shown to be more powerful than simpler convolutional GNNs (C-GNNs). However, A-GNNs are more complex to program and difficult to scale. To address this, we develop a novel mathematical formulation, based on tensors that group all the feature vectors, targeting both training and inference of A-GNNs. The formulation enables straightforward adoption of communication-minimizing routines, it fosters optimizations such as vectorization, and it enables seamless integration with established linear algebra DSLs or libraries such as GraphBLAS. Our implementation uses a data redistribution scheme explicitly developed for sparse-dense tensor operations used heavily in GNNs, and fusing optimizations that further minimize memory usage and communication cost. We ensure theoretical asymptotic reductions in communicated data compared to the established message-passing GNN paradigm. Finally, we provide excellent scalability and speedups of even 4--5x over modern libraries such as Deep Graph Library.

28 May 2026 in NEJM AI
Verified
Journal Article
Closed access
MMMatthew B. A. McDermott
Matthew B. A. McDermott
ESEthan Steinberg
Ethan Steinberg
JFJason A. Fries
Jason A. Fries
RWRobin Philippus van de Water
Robin Philippus van de Water
CPChao Pang
Chao Pang
NSNigam H. Shah
Nigam H. Shah

1 January 2022
Verified
Book Chapter
Closed access
JWJarosław Wąs
Jarosław Wąs
DPDariusz Pałka
Dariusz Pałka
GBGrzegorz Bazior
Grzegorz Bazior
RLRobert Lubaś
Robert Lubaś
MTMichał Turek
Michał Turek
MPMichał Pikus
Michał Pikus